Abstract
Summary
LPI (LP Information)' newest research report, the “Orthopedic Regenerative Medicine Industry Forecast” looks at past sales and reviews total world Orthopedic Regenerative Medicine sales in 2022, providing a comprehensive analysis by region and market sector of projected Orthopedic Regenerative Medicine sales for 2023 through 2029. With Orthopedic Regenerative Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Orthopedic Regenerative Medicine industry.
This Insight Report provides a comprehensive analysis of the global Orthopedic Regenerative Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Orthopedic Regenerative Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Orthopedic Regenerative Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Orthopedic Regenerative Medicine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Orthopedic Regenerative Medicine.
The global Orthopedic Regenerative Medicine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Orthopedic Regenerative Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Orthopedic Regenerative Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Orthopedic Regenerative Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Orthopedic Regenerative Medicine players cover Ortho Regenerative Technologies Inc, Personalized stem cells Inc., Anika Therapeutics Inc., Arthrex Inc., Baxter International Inc., Conmed Corporation, Aziyo Biologics, Curasan Inc. and Swiss biomed Orthopedics AG, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Orthopedic Regenerative Medicine market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Stem Cell Therapy (Allogeneic Bones, Autogeneic Bones, and Bone Grafting)
Plasma Based Therapy
Tissue Engineering (Allograft)
Segmentation by application
Osteoarticular Diseases
Rheumatoid Arthritis
Ligament Injuries
Bursitis
Osteoporosis
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Ortho Regenerative Technologies Inc
Personalized stem cells Inc.
Anika Therapeutics Inc.
Arthrex Inc.
Baxter International Inc.
Conmed Corporation
Aziyo Biologics
Curasan Inc.
Swiss biomed Orthopedics AG
Octane Medical Inc.
Stryker Corporation
Carmell Therapeutics Corporation
Zimmer Holdings
Smith & Nephew plc.
NuVasive Inc.
This Insight Report provides a comprehensive analysis of the global Orthopedic Regenerative Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Orthopedic Regenerative Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Orthopedic Regenerative Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Orthopedic Regenerative Medicine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Orthopedic Regenerative Medicine.
The global Orthopedic Regenerative Medicine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Orthopedic Regenerative Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Orthopedic Regenerative Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Orthopedic Regenerative Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Orthopedic Regenerative Medicine players cover Ortho Regenerative Technologies Inc, Personalized stem cells Inc., Anika Therapeutics Inc., Arthrex Inc., Baxter International Inc., Conmed Corporation, Aziyo Biologics, Curasan Inc. and Swiss biomed Orthopedics AG, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Orthopedic Regenerative Medicine market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Stem Cell Therapy (Allogeneic Bones, Autogeneic Bones, and Bone Grafting)
Plasma Based Therapy
Tissue Engineering (Allograft)
Segmentation by application
Osteoarticular Diseases
Rheumatoid Arthritis
Ligament Injuries
Bursitis
Osteoporosis
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Ortho Regenerative Technologies Inc
Personalized stem cells Inc.
Anika Therapeutics Inc.
Arthrex Inc.
Baxter International Inc.
Conmed Corporation
Aziyo Biologics
Curasan Inc.
Swiss biomed Orthopedics AG
Octane Medical Inc.
Stryker Corporation
Carmell Therapeutics Corporation
Zimmer Holdings
Smith & Nephew plc.
NuVasive Inc.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Orthopedic Regenerative Medicine Market Size 2018-2029
2.1.2 Orthopedic Regenerative Medicine Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Orthopedic Regenerative Medicine Segment by Type
2.2.1 Stem Cell Therapy (Allogeneic Bones, Autogeneic Bones, and Bone Grafting)
2.2.2 Plasma Based Therapy
2.2.3 Tissue Engineering (Allograft)
2.3 Orthopedic Regenerative Medicine Market Size by Type
2.3.1 Orthopedic Regenerative Medicine Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Orthopedic Regenerative Medicine Market Size Market Share by Type (2018-2023)
2.4 Orthopedic Regenerative Medicine Segment by Application
2.4.1 Osteoarticular Diseases
2.4.2 Rheumatoid Arthritis
2.4.3 Ligament Injuries
2.4.4 Bursitis
2.4.5 Osteoporosis
2.5 Orthopedic Regenerative Medicine Market Size by Application
2.5.1 Orthopedic Regenerative Medicine Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Orthopedic Regenerative Medicine Market Size Market Share by Application (2018-2023)
3 Orthopedic Regenerative Medicine Market Size by Player
3.1 Orthopedic Regenerative Medicine Market Size Market Share by Players
3.1.1 Global Orthopedic Regenerative Medicine Revenue by Players (2018-2023)
3.1.2 Global Orthopedic Regenerative Medicine Revenue Market Share by Players (2018-2023)
3.2 Global Orthopedic Regenerative Medicine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Orthopedic Regenerative Medicine by Regions
4.1 Orthopedic Regenerative Medicine Market Size by Regions (2018-2023)
4.2 Americas Orthopedic Regenerative Medicine Market Size Growth (2018-2023)
4.3 APAC Orthopedic Regenerative Medicine Market Size Growth (2018-2023)
4.4 Europe Orthopedic Regenerative Medicine Market Size Growth (2018-2023)
4.5 Middle East & Africa Orthopedic Regenerative Medicine Market Size Growth (2018-2023)
5 Americas
5.1 Americas Orthopedic Regenerative Medicine Market Size by Country (2018-2023)
5.2 Americas Orthopedic Regenerative Medicine Market Size by Type (2018-2023)
5.3 Americas Orthopedic Regenerative Medicine Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Orthopedic Regenerative Medicine Market Size by Region (2018-2023)
6.2 APAC Orthopedic Regenerative Medicine Market Size by Type (2018-2023)
6.3 APAC Orthopedic Regenerative Medicine Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Orthopedic Regenerative Medicine by Country (2018-2023)
7.2 Europe Orthopedic Regenerative Medicine Market Size by Type (2018-2023)
7.3 Europe Orthopedic Regenerative Medicine Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Orthopedic Regenerative Medicine by Region (2018-2023)
8.2 Middle East & Africa Orthopedic Regenerative Medicine Market Size by Type (2018-2023)
8.3 Middle East & Africa Orthopedic Regenerative Medicine Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Orthopedic Regenerative Medicine Market Forecast
10.1 Global Orthopedic Regenerative Medicine Forecast by Regions (2024-2029)
10.1.1 Global Orthopedic Regenerative Medicine Forecast by Regions (2024-2029)
10.1.2 Americas Orthopedic Regenerative Medicine Forecast
10.1.3 APAC Orthopedic Regenerative Medicine Forecast
10.1.4 Europe Orthopedic Regenerative Medicine Forecast
10.1.5 Middle East & Africa Orthopedic Regenerative Medicine Forecast
10.2 Americas Orthopedic Regenerative Medicine Forecast by Country (2024-2029)
10.2.1 United States Orthopedic Regenerative Medicine Market Forecast
10.2.2 Canada Orthopedic Regenerative Medicine Market Forecast
10.2.3 Mexico Orthopedic Regenerative Medicine Market Forecast
10.2.4 Brazil Orthopedic Regenerative Medicine Market Forecast
10.3 APAC Orthopedic Regenerative Medicine Forecast by Region (2024-2029)
10.3.1 China Orthopedic Regenerative Medicine Market Forecast
10.3.2 Japan Orthopedic Regenerative Medicine Market Forecast
10.3.3 Korea Orthopedic Regenerative Medicine Market Forecast
10.3.4 Southeast Asia Orthopedic Regenerative Medicine Market Forecast
10.3.5 India Orthopedic Regenerative Medicine Market Forecast
10.3.6 Australia Orthopedic Regenerative Medicine Market Forecast
10.4 Europe Orthopedic Regenerative Medicine Forecast by Country (2024-2029)
10.4.1 Germany Orthopedic Regenerative Medicine Market Forecast
10.4.2 France Orthopedic Regenerative Medicine Market Forecast
10.4.3 UK Orthopedic Regenerative Medicine Market Forecast
10.4.4 Italy Orthopedic Regenerative Medicine Market Forecast
10.4.5 Russia Orthopedic Regenerative Medicine Market Forecast
10.5 Middle East & Africa Orthopedic Regenerative Medicine Forecast by Region (2024-2029)
10.5.1 Egypt Orthopedic Regenerative Medicine Market Forecast
10.5.2 South Africa Orthopedic Regenerative Medicine Market Forecast
10.5.3 Israel Orthopedic Regenerative Medicine Market Forecast
10.5.4 Turkey Orthopedic Regenerative Medicine Market Forecast
10.5.5 GCC Countries Orthopedic Regenerative Medicine Market Forecast
10.6 Global Orthopedic Regenerative Medicine Forecast by Type (2024-2029)
10.7 Global Orthopedic Regenerative Medicine Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Ortho Regenerative Technologies Inc
11.1.1 Ortho Regenerative Technologies Inc Company Information
11.1.2 Ortho Regenerative Technologies Inc Orthopedic Regenerative Medicine Product Offered
11.1.3 Ortho Regenerative Technologies Inc Orthopedic Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Ortho Regenerative Technologies Inc Main Business Overview
11.1.5 Ortho Regenerative Technologies Inc Latest Developments
11.2 Personalized stem cells Inc.
11.2.1 Personalized stem cells Inc. Company Information
11.2.2 Personalized stem cells Inc. Orthopedic Regenerative Medicine Product Offered
11.2.3 Personalized stem cells Inc. Orthopedic Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Personalized stem cells Inc. Main Business Overview
11.2.5 Personalized stem cells Inc. Latest Developments
11.3 Anika Therapeutics Inc.
11.3.1 Anika Therapeutics Inc. Company Information
11.3.2 Anika Therapeutics Inc. Orthopedic Regenerative Medicine Product Offered
11.3.3 Anika Therapeutics Inc. Orthopedic Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Anika Therapeutics Inc. Main Business Overview
11.3.5 Anika Therapeutics Inc. Latest Developments
11.4 Arthrex Inc.
11.4.1 Arthrex Inc. Company Information
11.4.2 Arthrex Inc. Orthopedic Regenerative Medicine Product Offered
11.4.3 Arthrex Inc. Orthopedic Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Arthrex Inc. Main Business Overview
11.4.5 Arthrex Inc. Latest Developments
11.5 Baxter International Inc.
11.5.1 Baxter International Inc. Company Information
11.5.2 Baxter International Inc. Orthopedic Regenerative Medicine Product Offered
11.5.3 Baxter International Inc. Orthopedic Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Baxter International Inc. Main Business Overview
11.5.5 Baxter International Inc. Latest Developments
11.6 Conmed Corporation
11.6.1 Conmed Corporation Company Information
11.6.2 Conmed Corporation Orthopedic Regenerative Medicine Product Offered
11.6.3 Conmed Corporation Orthopedic Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Conmed Corporation Main Business Overview
11.6.5 Conmed Corporation Latest Developments
11.7 Aziyo Biologics
11.7.1 Aziyo Biologics Company Information
11.7.2 Aziyo Biologics Orthopedic Regenerative Medicine Product Offered
11.7.3 Aziyo Biologics Orthopedic Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Aziyo Biologics Main Business Overview
11.7.5 Aziyo Biologics Latest Developments
11.8 Curasan Inc.
11.8.1 Curasan Inc. Company Information
11.8.2 Curasan Inc. Orthopedic Regenerative Medicine Product Offered
11.8.3 Curasan Inc. Orthopedic Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Curasan Inc. Main Business Overview
11.8.5 Curasan Inc. Latest Developments
11.9 Swiss biomed Orthopedics AG
11.9.1 Swiss biomed Orthopedics AG Company Information
11.9.2 Swiss biomed Orthopedics AG Orthopedic Regenerative Medicine Product Offered
11.9.3 Swiss biomed Orthopedics AG Orthopedic Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Swiss biomed Orthopedics AG Main Business Overview
11.9.5 Swiss biomed Orthopedics AG Latest Developments
11.10 Octane Medical Inc.
11.10.1 Octane Medical Inc. Company Information
11.10.2 Octane Medical Inc. Orthopedic Regenerative Medicine Product Offered
11.10.3 Octane Medical Inc. Orthopedic Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Octane Medical Inc. Main Business Overview
11.10.5 Octane Medical Inc. Latest Developments
11.11 Stryker Corporation
11.11.1 Stryker Corporation Company Information
11.11.2 Stryker Corporation Orthopedic Regenerative Medicine Product Offered
11.11.3 Stryker Corporation Orthopedic Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Stryker Corporation Main Business Overview
11.11.5 Stryker Corporation Latest Developments
11.12 Carmell Therapeutics Corporation
11.12.1 Carmell Therapeutics Corporation Company Information
11.12.2 Carmell Therapeutics Corporation Orthopedic Regenerative Medicine Product Offered
11.12.3 Carmell Therapeutics Corporation Orthopedic Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Carmell Therapeutics Corporation Main Business Overview
11.12.5 Carmell Therapeutics Corporation Latest Developments
11.13 Zimmer Holdings
11.13.1 Zimmer Holdings Company Information
11.13.2 Zimmer Holdings Orthopedic Regenerative Medicine Product Offered
11.13.3 Zimmer Holdings Orthopedic Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Zimmer Holdings Main Business Overview
11.13.5 Zimmer Holdings Latest Developments
11.14 Smith & Nephew plc.
11.14.1 Smith & Nephew plc. Company Information
11.14.2 Smith & Nephew plc. Orthopedic Regenerative Medicine Product Offered
11.14.3 Smith & Nephew plc. Orthopedic Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Smith & Nephew plc. Main Business Overview
11.14.5 Smith & Nephew plc. Latest Developments
11.15 NuVasive Inc.
11.15.1 NuVasive Inc. Company Information
11.15.2 NuVasive Inc. Orthopedic Regenerative Medicine Product Offered
11.15.3 NuVasive Inc. Orthopedic Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 NuVasive Inc. Main Business Overview
11.15.5 NuVasive Inc. Latest Developments
12 Research Findings and Conclusion